Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic response and PSMA imaging correlates.

被引：0
|
作者：
Bastos, Diogo Assed
Coelho, Rafael
Cardili, Leonardo
Galiza, Felipe
Ilario, Eder Nisi
Viana, Ublio
Murta, Claudio Bovolenta
Guglielmetti, Giuliano
Cordeiro, Mauricio
Pontes, Jose, Jr.
Muniz, David Queiroz Borges
Silva, Jamile Almeida
Mota, Jose Mauricio
De Freitas, Guilherme Fialho
Leite, Katia Ramos Moreira
Buchpiguel, Carlos Alberto
Nahas, William Carlos
机构：
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[2] Hosp Brigadeiro, Sao Paulo, Brazil
[3] Univ Sao Paulo, Med Sch, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5085
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant IMC-A12 and combined androgen deprivation with prostatectomy for high-risk prostate cancer: A phase II trial
    Dean, J. P.
    Plymate, S. R.
    Dalkin, B. L.
    Ellis, W. J.
    Lin, D. W.
    Wright, J. L.
    Corman, J. M.
    True, L. D.
    Lange, P. H.
    Montgomery, R. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
    Devos, Gaetan
    Tosco, Lorenzo
    Baldewijns, Marcella
    Gevaert, Thomas
    Goffin, Karolien
    Petit, Valentin
    Mai, Cindy
    Laenen, Annouschka
    Raskin, Yannic
    Van Haute, Carl
    Goeman, Lieven
    De Meerleer, Gert
    Berghen, Charlien
    Devlies, Wout
    Claessens, Frank
    Van Poppel, Hendrik
    Everaerts, Wouter
    Joniau, Steven
    [J]. EUROPEAN UROLOGY, 2023, 83 (06) : 508 - 518
  • [23] Phase II trial of external radiotherapy, brachytherapy, androgen deprivation and docetaxel chemotherapy for high-risk, localized prostate cancer
    DiBiase, SJ
    Dawson, N
    Kwok, Y
    Kataria, R
    Hussain, A
    Nagda, S
    Bangalore, M
    Amin, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S296 - S297
  • [24] Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Makino, Tomoyuki
    Mizokami, Atsushi
    [J]. CANCERS, 2022, 14 (07)
  • [25] Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer
    Eapen, Renu S.
    Williams, Scott G.
    Macdonald, Sean
    Keam, Simon P.
    Lawrentschuk, Nathan
    Au, Lewis
    Hofman, Michael S.
    Murphy, Declan G.
    Neeson, Paul J.
    [J]. NATURE REVIEWS UROLOGY, 2024,
  • [26] Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
    Aggarwal, Rahul
    Alumkal, Joshi J.
    Szmulewitz, Russell Z.
    Higano, Celestia S.
    Bryce, Alan H.
    Lopez-Gitlitz, Angela
    McCarthy, Sharon A.
    Miladinovic, Branko
    McQuarrie, Kelly
    Thomas, Shibu
    Zhang, Ke
    Small, Eric J.
    [J]. PROSTATE CANCER, 2022, 2022
  • [27] Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer
    Lee, Tae Hoon
    Pyo, Hongryull
    Yoo, Gyu Sang
    Jeon, Seong Soo
    Seo, Seong Il
    Jeong, Byong Chang
    Jeon, Hwang Gyun
    Sung, Hyun Hwan
    Kang, Minyong
    Song, Wan
    Chung, Jae Hoon
    Bae, Bong Kyung
    Park, Won
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2024, 68 (03) : 333 - 341
  • [28] Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer
    Nishiyama, Tsutomu
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2012, 129 (3-5): : 179 - 190
  • [29] Neoadjuvant pamiparib plus abiraterone and ADT for high-risk/very high-risk localized prostate cancer: Results of a prospective study
    Zhuang, J.
    Zhang, S.
    Qiu, X.
    Zhou, F.
    Guo, H.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S1532 - S1532
  • [30] Results of a phase II trial of intense androgen deprivation therapy prior to radical prostatectomy (RP) in men with high-risk localized prostate cancer (PC).
    McKay, Rana R.
    Xie, Wanling
    Fennessy, Fiona M.
    Zhang, Zhenwei
    Lis, Rosina
    Rathkopf, Dana E.
    Laudone, Vincent Paul
    Bubley, Glenn
    Einstein, David Johnson
    Chang, Peter
    Wagner, Andrew
    Preston, Mark A.
    Kilbridge, Kerry L.
    Chang, Steven Lee
    Choudhury, Atish Dipankar
    Pomerantz, Mark
    Quoc-Dien Trinh
    Kibel, Adam S.
    Taplin, Mary-Ellen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345